Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

in part by lower legal fees.

Jazz Pharmaceuticals' unrestricted cash, cash equivalents and marketable securities balance as of December 31, 2007 was $102.9 million. Net operating cash used during the year ended December 31, 2007 was $81.1 million.

Recent Highlights

-- On January 31, 2008, Jazz Pharmaceuticals announced that the U.S. Food

and Drug Administration (FDA) had accepted for review the submission of

the response by Solvay Pharmaceuticals, Inc. to the FDA approvable

letter for LUVOX CR. The FDA notified Solvay Pharmaceuticals that it

considered this a complete, class 1 response and the PDUFA action date

is February 29, 2008. In an approvable letter received on

December 21, 2007, the FDA had requested additional information

concerning a chemistry, manufacturing and control (CMC) issue. The

approvable letter did not raise any questions related to safety or

efficacy of LUVOX CR and included the FDA's proposed labeling. Jazz

Pharmaceuticals and Solvay Pharmaceuticals believe that the response

submitted to the FDA on December 28, 2007 fully addressed that CMC

issue.

-- Jazz Pharmaceuticals has completed the expansion of its sales force,

and now has a total of approximately 200 field sales personnel,

including sales management and sales representatives. These

individuals are currently in their assigned sales territories promoting

Xyrem.

-- In early January 2008, Jazz Pharmaceuticals announced that it had

received orphan drug designation from the FDA for its JZP-8 product

candidate for the treatment of recurrent acute repetitive seizures.

JZP-8 is a novel drug delivery formulation incorporating clonazepam, a

widely prescribed benzodiazepine. The product candidate is designed to

be a fast-acting intranasal spray for the treatment of re
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., the ... relaunch of his highly informative blog, now named Stem Cells ... are Stem Cells ?” Dr. Harman’s purpose for blogging ... basics of stem cell therapy so that pet owners can ... when considering regenerative medicine. , A veterinarian by trade, Dr. ...
(Date:7/10/2014)... Senior supply chain management executives from over 50 ... of “Reducing Cost, Lead Time, & Defects in the ... the partnership of the Bio Supply Management Alliance ( ... SCMI) of the University of San Diego in ... Institute of Peace and Justice in San Diego, Devendra ...
(Date:7/10/2014)... DALLAS , July 10, 2014  Kainos Capital, ... consumer brands, today announced that it has acquired the ... stake in the business. Terms of the transaction were ... loss and meal replacement business that markets ready-to-drink shakes, ... North America and in the ...
(Date:7/10/2014)... Calif., July 10, 2014   Ceres, Inc . ... seed company, announced today financial results for the three ... on its business. Ceres reported that the ... product performance this growing season in Brazil, which concluded ... the company,s sorghum evaluation areas for part of the ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Kainos Capital Acquires Slim-Fast From Unilever 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... Proprietary Products Division of Par Pharmaceutical with Initial Focus on ... ... WOODCLIFF LAKE, N.J., Sept. 28 /PRNewswire-FirstCall/ - Par,Pharmaceutical Companies, Inc. ... marketing novel prescription drugs, through the,establishment and introduction of Strativa ...
... Mass., Sept. 28 Idenix,Pharmaceuticals, Inc. (Nasdaq: ... the discovery and development of drugs for ... a strategic restructuring. As part of the,restructuring, ... Novartis,Pharma AG related to Tyzeka(R)/Sebivo(R). Per the ...
... NORCROSS, Ga., Sept. 28 Immucor, Inc.,(Nasdaq: ... providing automated instrument-reagent,systems to the blood transfusion ... Commission (SEC) has agreed to a complete,settlement ... the company,s Italian subsidiary. Under the ...
Cached Biology Technology:Introducing Strativa Pharmaceuticals 2Introducing Strativa Pharmaceuticals 3Introducing Strativa Pharmaceuticals 4Introducing Strativa Pharmaceuticals 5Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 4Immucor Settles SEC Investigation 2
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
(Date:7/11/2014)... de Janeiro, Brazil- In the brains of all ... that allows an electric or chemical signal to ... Chemical synapses, which are the most abundant type ... Synapse formation is crucial for learning, memory, perception ... inhibitory synapses critical for brain function. For ...
(Date:7/10/2014)... 2014  Aware, Inc. (NASDAQ: AWRE ), ... announced on June 26, 2014 that its Board of ... per share, or approximately $40 million in total.  The ... and a payment date of July 24, 2014.  The ... set an ex-dividend date for this special cash dividend. ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2
... that clean water and air are signs of a healthy ... the environment is right beneath their feet, according to a ... maintaining a clean environment by serving as a natural water ... and soil hydrology. Understanding the components that make up this ...
... State of the Union address, President Obama singled out climate ... can choose to believe that Superstorm Sandy, and the most ... have ever seen were all just a freak coincidence," he ... judgment of science and act before it,s too late." ...
... shift in U.S. demographics and importance of minorities took ... those growing toward majority acquire representation in our educational ... and move minorities forward to majorities in science, technology, ... gaining traction, said Castillo-Chavez, one of a trio of ...
Cached Biology News:Key to cleaner environment may be right beneath our feet 2Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 2Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 3Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 4Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 5Mentoring models to move minorities to majorities in STEM 2Mentoring models to move minorities to majorities in STEM 3
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
... HDAC8 Regulation of gene expression ... as DNA methylation, ATP-dependent chromatin remodeling, ... which include the dynamic acetylation and ... residues present in the tail of ...
...
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
Biology Products: